catalog number :
MBS690572
products full name :
Hamster Anti-Mouse CD80
products short name :
[CD80]
products name syn :
[Cd80; B71; Ly53; TSA1; Cd28l; Ly-53; MIC17]
other names :
[T-lymphocyte activation antigen CD80; T-lymphocyte activation antigen CD80; T-lymphocyte activation antigen CD80; B7 protein; activation B7-1 antigen; CD80 antigen; Activation B7-1 antigen]
products gene name :
[CD80]
other gene names :
[Cd80; Cd80; B71; Ly53; TSA1; Cd28l; Ly-53; MIC17; B7; B7]
uniprot entry name :
CD80_MOUSE
purity :
Protein G/A chromatography
storage stability :
Lyophilized samples are stable for 2 years from date of receipt when stored at -70 degree C. Reconstituted antibody can be aliquoted and stored frozen at < -20 degree C for at least for six months without detectable loss of activity.
tested application :
Immunohistochemistry (IHC), Flow Cytometry (FC/FACS)
app notes :
IHC (paraffine): 1:100-1:300. Flow cytometry: 1:100-1:1000
image1 heading :
Immunohistochemistry (IHC)
image2 heading :
Immunohistochemistry (IHC)
other info1 :
Antibody Generation: This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a Armenian Hamster immunized with recombinant Mouse CD80 protein. IgG fraction of the culture supernatant was purified by Protein G affinity chromatography. Reconstitution buffer: PBS(sterile). Antigen: Recombinant Mouse CD80 protein
other info2 :
Reconstitution: Reconstitute the antibody with 200 ul sterile PBS and the final concentration is 500 ug/ml. Remarks: This antibody was selected for its ability to detect mouse CD80.
products description :
B7-1 (CD80) and B7-2, together with their receptors CD28 and CTLA4, constitute one of the dominant costimulatory pathways that regulate T and B cell responses. Although both CTLA4 and CD28 can bind to the same ligands, CTLA4 binds to B7-1 and B7-2 with a 20-100 fold higher affinity than CD28 and is involved in the downregulation of the immune response. B7-1 is expressed on activated B cells, activated T cells, and macrophages. B7-2 is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells. Additionally, B7-2 is expressed at low levels on monocytes and can be upregulated through interferon gamma. B7-1 and B7-2 are both members of the Immunoglobulin superfamily.
ncbi acc num :
NP_033985.3
ncbi gb acc num :
NM_009855.2
ncbi pathways :
Adaptive Immune System Pathway (926013); Allograft Rejection Pathway (83316); Allograft Rejection Pathway (535); Autoimmune Thyroid Disease Pathway (83314); Autoimmune Thyroid Disease Pathway (533); CD28 Co-stimulation Pathway (926020); CD28 Dependent PI3K/Akt Signaling Pathway (926021); CD28 Dependent Vav1 Pathway (926022); CTLA4 Inhibitory Signaling Pathway (926023); Cell Adhesion Molecules (CAMs) Pathway (83266)
uniprot summary :
Function: Involved in the costimulatory signal essential for T lymphocytes activation. T-cell proliferation and cytokine production is induced by the binding of CD28 or CTLA-4 to this receptor. Subcellular location: Membrane; Single-pass type I membrane protein. Tissue specificity: Expressed on activated B-cells, gamma interferon stimulated monocytes and non-circulating B-cell malignancies. Developmental stage: Expressed between 4 and 12 hours post-activation. Protein was detected at cell surface at 24 hours and it's expression was maximal from 48 to 72 hours post-activation. Sequence similarities: Contains 1 Ig-like C2-type (immunoglobulin-like) domain.Contains 1 Ig-like V-type (immunoglobulin-like) domain.